The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bosco Armando Menezes & Emily Bosco Menezes
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bosco Armando Menezes and Emily Bosco Menezes (acting as persons acting in concert, but not part of the promoter/promoter group) have purchased 15,000 equity shares of Hindustan Bio Sciences Ltd through the open market on 22 January 2026. This acquisition took their combined shareholding from 4.98% (5,10,000 shares) to 5.12% (5,25,000 shares), crossing the 5% substantial acquisition threshold that triggers disclosure under SEBI's Takeover Regulations. The shares were bought solely by Bosco Armando Menezes, whose individual holding rose from 2.49% to 2.63%, while Emily Bosco Menezes' holding stayed unchanged at 2.49%. The company's total equity share capital remains 1,02,50,800 shares of Rs 10 each (Rs 10.25 crore).
Although the buyers are not classified as promoters, they have crossed the 5% regulatory threshold, which means further purchases of 2% or more would trigger additional open-offer obligations. For retail shareholders, this signals modest non-promoter accumulation in a small-cap pharma company, but no immediate takeover or material corporate action is implied.